Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: Effect of immunotherapy

Journal of Allergy and Clinical Immunology

Volumn 99, Issue 4, 1997, Pages 551-562

  Håkansson, Lena ^a   Heinrich, Christina ^b   Rak, Sabina ^a,c   Venge, Per ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

adhesion; Eosinophil; immunotherapy; intercellular adhesion molecule 1; macrophage antigen 1; neutrophil; pollen season; vascular cell adhesion molecule 1; very late activation antigen

Indexed keywords

ALLERGEN; CD11B ANTIGEN; CD18 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; METHACHOLINE; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN;

ADULT; ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANTIGEN EXPRESSION; ARTICLE; BLOOD CELL COUNT; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LUNG FUNCTION TEST; MALE; POLLEN; PRIORITY JOURNAL; SEASONAL VARIATION; TREATMENT OUTCOME;

EID: 0030895785     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70084-8     Document Type: Article

References (55)

1. Gleich GJ. The eosinophil and bronchial asthma: current under-standing. J Allergy Clin Immunol 1990;85:422-36.
2. Arm JP, Lee TH. The pathobiology of bronchial asthma. Adv Immunol 1992;51:323-82.
3. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
4. Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993;147:1126-31.
5. Tanizaki Y, Kitani H, Okazaki M, Mifune T, Mitsunobu F, Kimura I. Mucus hypersecretion and eosinophils in bronchoalveolar lavage fluid in adult patients with bronchial asthma. J Asthma 1993;30:257-62.
6. Lacoste J-Y, Bousquet J, Chanez F, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993;92:537-48.
7. Boner AL, Peroni DG, Piacentini GL, Venge P. Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy 1993;23:1021-6.
8. Rak S, Björnson A, Håkanson L, Sörenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991;88:878-88.
9. Håkansson L, Carlson M, Stålenheim G, Venge P. Migratory responses of eosinophil and neutrophil granulocytes from asthmatic patients. J Allergy Clin Immunol 1990;85:743-50.
10. Warringa RAJ, Mengelers HJJ, Raaijmakers JAM, Bruijnzeel PLB, Koenderman L. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol 1993;91:1198-205.
11. Butcher EC. Leukocyte-endothelial cell adhesion as an active, multi-step process: a combinatorial mechanism for specificity and diversity in leukocyte targeting. Adv Exp Med Biol 1992;323:181-94.
12. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804.
13. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
14. Bochner BS, Luscinskas FW, Gimbrone MA Jr, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:1553-6.
15. Dobrina A, Menegazzi R, Carlos TM, et al. Mechanisms of eosinophil adherence to cultured vascular endothelial cells: eosinophils bind to the cytokine-induced endothelial ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J Clin Invest 1991;88:20-6.
16. Sako D, Chang X-J, Barone KM, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993;75:1179-86.
17. Bochner BS, Sterbinsky SA, Bickel CA, Werfel S, Wein M, Newman W. Differences between human eosinophils and neutrophils in the function and expression of sialic acid-containing counterligands for E-selectin. J Immunol 1994;152:774-82.
18. Gosset P, Tillie-Leblond I, Janin A, et al. Increased expression of ELAM-1, ICAM-1, and VCAM-1 on bronchial biopsies from allergic asthmatic patients. Ann N Y Acad Sci 1994;725:163-72.
19. Ohkawara Y, Yamauchi K, Maruyama N, et al. In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with air flow limitation: in vivo evidence of VCAM-1/VLA-4 interaction in selective eosinophil infiltration. Am J Respir Cell Mol Biol 1995;12:4-12.
20. Gosset P, Tillie-Leblond I, Janin A, et al. Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients. Int Arch Allergy Immunol 1995;106:69-77.
21. Zangrilli JG, Shaver JR, Cirelli RA, et al. sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am J Respir Crit Care Med 1995;151:1346-53.
22. Håkansson L, Björnsson E, Janson C, Schmekel B. Increased adhesion to VCAM-1 and ICAM-1 of eosinophils from asthmatic patients. J Allergy Clin Immunol 1995;96:941-50.
23. Björnsson E, Janson C, Håkansson L, Enander I, Venge P, Boman G. Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population. Allergy 1994;49:730-6.
24. Löwhagen O, Lindholm NB. Short-term and long-term variation in bronchial response to histamine in asthmatic patients. Eur J Respir Dis 1983;64:466-72.
25. Hansel TT, De Vries IJM, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-10.
26. Håkansson L, Soegaard Nielsen L, Teder P. Measurement of neutrophil and eosinophil adhesion to E-selectin, VCAM-1 and ICAM-1 by the use of transfected fibroblast cell lines. J Immunol Methods 1994;176:53-66.
27. Saito H, Yamada K, Breard J, Yoshie O, Mathé G. A monoclonal antibody reactive with human eosinophils. Blood 1986;67:50-6.
28. Hansel TT, Braunstein JB, Walker C, et al. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 1991;86:271-7.
29. Ogden EC, Raynor GS, Hayes JV, Lewis DM, Haines JH. Manual for sampling airborne pollen. New York: Hafner, 1974.
30. Carlson M, Håkansson L, Kämpe M, Stålenheim G, Peterson C, Venge P. Degranulation of eosinophils from pollen atopic patients is increased during pollen season. J Allergy Clin Immunol 1992;89:131-9.
31. Rak S, Löwhagen O, Venge P. The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 1988;82:470-80.
32. Venge P, Dahl R, Peterson CG. Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication. Int Arch Allergy Appl Immunol 1988;87:306-12.
33. Wempe JB, Tammeling EP, Koëter GH, Håkansson L, Venge P, Postma DS. Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol. J Allergy Clin Immunol 1992;90:757-65.
34. Hamid Q, Azzawi M, Ying S, et al. Interleukin-5 mRNA in mucosal bronchial biopsies from asthmatic subjects. Int Arch Allergy Appl Immunol 1991;94:169-70.
35. Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary latephase reaction. Am Rev Respir Dis 1993;147:901-7.
36. Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients: relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest 1994;105:687-96.
37. Fukuda T, Nakajima H, Fukushima Y, et al. Detection of interleukin-5 messenger RNA and interleukin-5 protein in bronchial biopsies from asthma by nonradioactive in situ hybridization and immunohistochemistry. J Allergy Clin Immunol 1994;94(suppl):584-93.
38. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990;71:258-65.
39. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines: III-effect of the chemokine RANTES. J Immunol 1994;153:2153-60.
40. Ricci M, Rossi O, Bertoni M, Matucci A. The importance of Th2-like cells in the pathogenesis of airway allergic inflammation. Clin Exp Allergy 1993;23:360-9.
41. Del Prete GF, De Carli M, D'Elios MM, et al. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993;23:1445-9.
42. H2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313-24.
43. Moqbel R. Eosinophils, cytokines, and allergic inflammation. Ann N Y Acad Sci 1994;725:223-33.
44. Busse WW, Coffman RL, Gelfand EW, Kay AB, Rosenwasser LJ. Mechanisms of persistent airway inflammation in asthma: a role for T cells and T-cell products. Am J Respir Crit Care Med 1995;152:388-93.
45. Mosman TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone: definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
46. Kay AB, Ying S, Varney V, et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced latephase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-8.
47. Mosman TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
48. Rak S, Håkansson L, Venge P. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. J Allergy Clin Immunol 1990;86:706-13.
49. Romagnani S. Regulation and deregulation of human IgE synthesis. Immunol Today 1990;1:316-21.
50. Coffman RL, Seymour BW, Lebman LA, et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 1988;102:5-28.
51. Varney VA, Hamid QA, Gaga M, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-51.
52. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123-30.
53. Norman PS. Modern concepts of immunotherapy. Curr Opin Immunol 1993;5:968-73.
54. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 1995;154:4187-94.
55. McHugh SM, Deighton J, Stewart AG, Lachmann PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy 1995;25:828-38.